San Francisco, 17 December 2018, Women’s Health Diagnostics Market Size, Share
& Trends Analysis Report By End Use, By Application (Cancer, Infectious
Disease, Osteoporosis, Pregnancy, Prenatal), and Segment Forecasts, 2018 - 2025
The global women’s health diagnostics market size
is expected to reach USD 76.2 billion by 2025, according to a new report by
Grand View Research, Inc. Rising adoption of point-of-care diagnostics and
growing incidence of various chronic and lifestyle diseases are among the key
factors stimulating the growth of the market. Besides this, introducing various
awareness programs is also anticipated to work in favor the market during the
forecast period. For instance, in 2014, the European Commission launched joint
action for European Guide on Quality Improvement in Comprehensive Cancer
Control.
Women’s health diagnostics is witnessing
high growth due to increased funding from various organizations. For instance,
in May 2015, Abcodia received funding of USD 8.0 million from Cambridge
Innovative Capital, Scottish Equity Partners, Albion Ventures, and UCLB to
launch Risk of Ovarian Cancer Algorithm (ROCA) test in the U.K. for early
detection of ovarian cancer.
On the basis of end use, the market has been
bifurcated into hospital & diagnostics centers and home. Hospitals and
diagnostic centers accounted for a larger share in the market due to high
number of visits to hospitals and more reliable detection.
The market in Asia Pacific is likely to
witness significant growth over the coming years. The growth of the market can
be attributed to increasing investments in healthcare, growing focus of
international device manufacturers on strengthening their distribution networks
within the region, and epidemiological shift from infectious diseases to
chronic diseases within regional boundaries.
Access Full
Research Report On Women’s Health Diagnostics Market Analysis:
www.grandviewresearch.com/industry-analysis/womens-health-diagnostics-market
www.grandviewresearch.com/industry-analysis/womens-health-diagnostics-market
Further key findings from the report suggest:
·
Increasing investments by governments and
private bodies and rising disposable income are providing a push to the market
·
Cancer accounted for the highest share in
the market in 2017. The segment will register noteworthy growth during the
forecast period owing to availability of early detection tests and government
initiatives to tackle cancer
·
Prenatal testing is estimated to be the
fastest growing segment during the same period owing to rising prevalence of
prenatal diseases, increasing maternal age, surging healthcare expenditure, and
development of advanced diagnostic tests
·
Geographically, North America was the
leading revenue contributor to the women’s health diagnostics market in 2017.
It is anticipated to maintain its dominance through 2025, thanks to widening
base of diagnostic and imaging centers, mounting cases of cancer, growing
awareness about fertility testing, and spiraling adoption of point-of-care
testing devices
·
Some of the key players are Siemens
Healthcare Private Limited; Hologic, Inc.;GE Healthcare; F. Hoffmann-La Roche
Ltd.; bioMérieux SA; Koninklijke Philips N.V; Abbott; Becton, Dickinson and
Company, Quest Diagnostics, Inc.; and PerkinElmer, Inc.
Browse
More Reports Of This Category By Grand View Research At: www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has segmented the global women’s health diagnostics
market based on application, end use, and region:
Women’s Health Diagnostics Application
Outlook (Revenue, USD Million, 2014 - 2025)
·
Cancer
o
Breast Cancer Testing
o
Cervical Cancer Testing
o
Ovarian Cancer Testing
·
Infectious Disease Testing
·
Osteoporosis Testing
·
Pregnancy and Fertility Testing
·
Prenatal Testing
Women’s Health Diagnostics End Use Outlook
(Revenue, USD Million, 2014 - 2025)
·
Hospital and Diagnostics Centers
·
Home
Women’s Health Diagnostics Regional Outlook
(Revenue, USD Million, 2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
U.K.
o
Germany
·
Asia Pacific
o
Japan
o
China
·
Latin America
o
Brazil
o
Mexico
·
Middle East & Africa
o
South Africa
Access Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-womens-health-diagnostics-market
www.grandviewresearch.com/press-release/global-womens-health-diagnostics-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and
consulting company, registered in the State of California and headquartered in
San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For more information: www.grandviewresearch.com/
